I’m #hiring. Know anyone who might be interested? 👋😊
This content isn’t available here
Access this content and more in the LinkedIn app
Nilogen Oncosystems’ Post
More Relevant Posts
-
Make this summer a season of discovery with Nilogen’s 3D ex vivo technology. Get rapid, actionable results and accelerate your journey from discovery to clinical application. For more information, visit www.nilogen.com or contact us at BD@nilogen.com.
-
Join us for a special LinkedIn Live interview on June 19 at 9 am PDT with Rikhia Chakraborty, Nilogen Oncosystems’ CSO. Explore the forefront of cancer technology with insights into our tumoroid platforms and discover how Nilogen is shaping the future of immuno-oncology, improving clinical outcome predictability. In conversation with Hersh Ashish Chaturvedi, VP with Strategic Partnerships, we will dive into the complexities of maintaining the tumor microenvironment and harnessing AI in biomedical research. Save the date and don't miss this exclusive opportunity to learn about the cutting-edge technologies in cancer research! #NilogenOncosystems #CancerResearch #Immunotherapy #BiomedicalInnovation #LinkedInLive #HealthcareTechnology #Tumoroidplatforms https://lnkd.in/gWN6btdp
Join us for an exclusive LinkedIn Live interview on June 19 at 9 am PDT with Rikhia Chakraborty, a leading expert from Nilogen Oncosystems. Rikhia will delve into the cutting-edge technologies revolutionizing cancer research, including their innovative use of tumoroid platforms and high throughput testing. Discover how Nilogen’s pioneering approaches are enhancing the predictability of clinical outcomes and transforming immuno-oncology. This insightful conversation with Hersh Ashish Chaturvedi, our VP - Strategic Partnerships, will explore the challenges and breakthroughs in maintaining the tumor microenvironment and leveraging AI in biomedical research. Don't miss this opportunity to gain valuable insights into the future of cancer therapy. Mark your calendars and join us live! #linkedinlive #biotechnology #tumorresearch #infinitalab
Ex Vivo Approaches to Cancer Treatment Development & Screening
www.linkedin.com
-
We're thrilled to announce our participation at ASCO 2024! Visit us at Booth #35094 to discover why our advanced tumoroid platform is revolutionizing preclinical studies. 🔬 Why Tumoroids? Tumoroids offer a cutting-edge alternative to traditional 3D systems, providing more realistic models that closely mimic human cancer environments. This leap in technology enables more accurate and predictive analyses, setting a new standard for oncology research. 🤝 Meet Our Experts: Drop by to chat with our representatives William Coward, Jared Ehrhart, and Carlo Petruzziello. They're eager to share insights and discuss how Nilogen's innovative solutions can accelerate your research. Don't miss the opportunity to learn about the future of preclinical studies with us at ASCO 2024. See you there! #ASCO2024
-
-
#AACR2024 #nilogenoncosystems #exvivotumormodel POSTER NUMBER #6782
Immunologist | Microscopy and Flow Cytometry Expert | High-Throughput Solutions for Life Sciences | Developed ICCE (First high through-put imaging based inflammasome evaluation assay)
Visit our poster at section 6 poster board 20 to explore the intricacies of our state-of-the-art technology and gain insights into leveraging tumoroids for your experiments. Discover cutting-edge methodologies and techniques to optimize your research endeavors. Meet with Rikhia Chakraborty and Jared Ehrhart and learn more about our tumor model platforms. Nilogen Oncosystems #AACR2024
-
-
Exciting news! Nilogen Oncosystems is thrilled to announce our presence at AACR 2024! 🎉 We cordially invite you to visit our booth to discover more about our groundbreaking advancements in oncology research. Learn firsthand about our innovative approaches and cutting-edge solutions aimed at revolutionizing cancer therapeutics. Don't miss this opportunity to engage with our team and explore the future of oncology. See you there! #AACR2024 #OncologyResearch #3dcancermodel #precisiononcology #NilogenOncosystems
-
